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1. Introduction 
Factor IX is the zymogen of a serine protease 
involved in the middle phase of the intrinsic pathway 
of blood coagulation and, like four other coagulation 
factors, prothrombin, factor X, factor VII and 
protein C, requires vitamin K for its biosynthesis [l] . 
The vitamin K-dependent modification was recently 
shown to lead to a series of r-carboxyglutamyl 
residues located in amino-terminal region of the 
molecule [2-S]. 
During the study of the ammo acid sequence of 
the amino-terminal segment of bovine factor IX, 
(obtained by activation of factor IX by a protease 
from Russell’s viper venom [6] ), we observed that 
cyanogen bromide cleaved not only the single 
methionyl bond but also, in an unexpected manner, 
peptide bonds in a region which is rich in r-carboxy- 
glutamyl residues. 
The present communication identifies the sites of 
cleavage by cyanogen bromide and indicates that 
other bromine-containing reagents such as N-bromo- 
succinimide and BNPS-skatole (bromine adduct of 
2-(2nitrophenyl sulfenyl)3-methyl indole) effect 
similar cleavage. 
2. Materials and methods 
Bovine factor IX, [6] was generously supplied by 
Dr Kazuo Fujikawa of this Department. The amino- 
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terminal segment (residues l-l 8 1) was isolated by 
chromatography on a column of SP-Sephadex C-25 
in the presence of 7 M urea after reduction and 
pyridylethylation of active factor IX,. A hepta- 
peptide (residues 5-l 1) was prepared by successive 
digestion of fragment CB II (residues l-6 1) with 
trypsin and subtilisin as described below. The 
sequence of this peptide has been determined in 
[7] ; two residues in the sequence were subsequently 
identified in [S] as y-carboxyglutamyl residues. 
Cyanogen bromide was a product of Eastman 
(reagent grade) or Pierce. BNPS-skatole and N-bromo- 
succinimide were obtained from Pierce and Nutritional 
Biochemicals, respectively. DCaZlo-Hydroxyglutamic 
acid was obtained from US Biochemical Co. 
Cleavage with cyanogen bromide was carried out 
at room temperature [8] or 4°C [9] in 70% formic acid 
for various periods of time. The reaction mixture was 
diluted with water and lyophilized. Reaction with 
N-bromosuccinimide was carried out at room temper- 
ature in 70% acetic acid for 30 min and terminated 
by adding a small amount of 88% formic acid [lo] . 
Reaction with BNPS-skatole was performed at room 
temperature in 80% acetic acid for various periods 
of time [ 1 I] . The reaction mixture was diluted with 
an equal volume of water and excess reagent extracted 
with I-chlorobutane. 
Peptides were separated by gel filtration and high 
voltage paper electrophoresis. Amino acid analyses 
were performed on a Durrum Amino Acid Analyzer 
(Model D-500). Automated Edman degradations were 
carried out on a Beckman Sequencer (Model 890B) 
by the method in [ 121. SDS-urea gel electrophoresis 
was performed by the method in [ 131. 
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3. Results and discussion 1.0 , 
Since amino acid analysis indicated the presence of 
one methionine residue/m01 amino-terminal segment 
(residues I- 18 1) of factor IX,, cleavage with cyano- 
gen bromide was expected to generate two fragments. 
The gel filtration profiles of products with cyanogen 
bromide at room temperature for 24 h and at 4“C 
for 7 h are shown in fig. 1A and 1 B, respectively. 
Fraction 1 in fig.lA and 1B was further separated by 
gel filtration on a column of Sephadex G-75 into the 
unreacted segment and a homogenous fragment, CB 1. 
Fraction 2 of fig.lB contained another homogenous 
fragment, CB II. Amino acid and sequence analyses 
indicated that CB I and CB II corresponded to
residues 62-l 8 1 and l-6 1 of the amino-terminal 
segment, respectively. Three fragments were isolated 
by gel filtration on a column (1.5 X 150 cm) of 
Sephadex G-50 superfine in 0.1 M N&HCOs from 
fraction 2 of fig. 1 A and shown to be residues 28-61, 
3 l-6 1 and 37-6 1, respectively, by amino acid and 
sequence analyses. Similar analyses indicated that a 
fragment isolated by paper electrophoresis, at pH 6.5, 
from fraction 3 of fig.lA comprised residues 41-61. 
As judged by SDS-urea gel electrophoresis, CB II 
was itself stable in 70% formic acid at room temper- 
ature for 3 days, but in the presence of cyanogen 
bromide under the same conditions, it was rapidly 
degraded. After 1,2 and 3 days, respectively, 39%, 
17% and 7% of the initial product remained. 
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These results uggest that cyanogen bromide or 
some impurity in the reagent cleaves the peptide 
bond at the carboxyl side of y-carboxyglutamyl 
residues as shown in tig.2. 
Fig.1. Gel filtration of digests of the amino-terminal segment 
(residues 1-181) of bovine factor IXaa with cyanogen 
bromide. Digests prepared at room temperature for 24 h (A) 
and at 4°C for 7 h (B) were applied to a column (2.5 X 115 cm) 
of Sephadex G-50 Superfine in 9% formic acid and eluted 
at a flow rate of 24 ml/h. Fractions of 4 ml were collected 
and pooled as indicated. 
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Fig.2. Partial sequence of the amino-terminal segment of bovine factor DCaa and the sites cleaved by cyanogen bromide (indicated 
by arrows). The sequence of bovine factor X is shown for comparison. Gla* denotes T-carboxyglutamyl residues tentatively 
identified and placed by the homology between bovine factors IX and X in this region of the molecules [5,14,15]. 
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Fig.3. Cleavage of a heptapeptide (residue 5-11 of bovine 
factor IX) containing 2 warboxyglutamyl residues. The 
peptide was treated with 4000 equiv. cyanogen bromide in 
70% formic acid for 3 days, 2 equiv. of N-bromosuccinimide 
in 70% acetic acid for 30 min OX 20 equiv. BNPS-skatole in 
80% acetic acid for 5 h, and then the product separated by 
electrophoresis, at pH 6.5, for 1 h at 2000 V. Peptides were 
eluted and identified by amino acid analysis to be Phe-Val- 
Arg (labelled l), Lys-Leu-X (2), intact peptide (3) and 
Lys-Leu-Gla-X (4). 
In order to confirm this interpretation, a hepta- 
peptide of known sequence containing 2T-carboxy- 
glutamyl residues (Gla), i.e., Lys-Leu-Gla-Gla- 
Phe-Val-Arg, was treated in a similar manner at 
room temperature for 3 days. Two major peptides 
(labelled 1 and 2 in tig.3) and one minor peptide 
(4 in fig.3) were observed. Similar results were 
obtained for the product of reaction with N-bromo- 
succinimide (fig.3); in this case, 2 equiv. reagent 
completely degraded the peptide in 30 min at room 
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temperature, generating 3 subpeptides. Amino acid 
analysis after acid hydrolysis indicated that the 
cationic peptide (labelled 1) was The-Val-Arg and 
the neutral peptide (labelled 2) Lys-Leu-X. X refers 
to an unknown ammo acid derivative which is generated 
from -rcarboxyglutamyl residue during the cleavage 
reaction. After acid hydrolysis of the peptide, this 
derivative is eluted on a Durrum Amino Acid Analyzer 
at a position in close proximity to DLulZo-hydroxy- 
glutamic acid, but its chemical structure is unknown. 
The minor peptide (labelled 4) was Lys-Leu-Gla-X. 
BNF’S-skatole also cleaved the heptapeptide atthe 
sites identical to those cleaved by cyanogen bromide 
and by IV-bromosuccinimide, but more than 10 equiv. 
reagent and 5 h were necessary to complete the 
cleavage. 
The present results indicate that brominating 
reagents such as N-bromosuccinimide and BNPS- 
skatole cleave -/-carboxyglutamyl peptide bonds. The 
cleavage with cyanogen bromide may be due to the 
reagent i self or bromine preexistent in the reagent. 
A hypothetical mechanism for cleavage isshown in 
fig.4. The -/-carboxyglutamyl residue is brominated 
at the y-carbon and the peptide bond subsequently 
cleaved via its iminolactone. The new carboxyl- 
terminal residue, therefore, may be a lactonized form 
of y-hydroxy-y’carboxy-glutamic acid, since the 
peptide Lys-Leu-X is neutral in charge, at pH 6.5. 
While this observation i itially complicated our 
analysis of the sequence of both factors IX [ 141 and 
X [ 151, elucidation of the site of anomalous cleavage 
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Fig.4. A hypothetical mechanism for the cleavage of t-carboxyglutamyl peptide bond by bromo-reagents. 
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now facilitates our examination of this region of 
factor IX. 
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